k c arulprakasam (6 resultados)

Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: K.C. ArulprakasamArul Prakasam K.C.M.Pharm., Department of pharmacy practice,JSS College of Pharmacy,OOTY,Tamil Nadu, IndiaDiabetes mellitus has become a major cause of illness and disability across the world. The number of peop.

Kartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: K.C. ArulprakasamArul Prakasam KC, M.Pharm., Asst.prof., Department of Pharmacy PracticeJKKMMRF college of pharmacy, Komarapalayam,namakkal Dt, Tamil Nadu, INDIA,According to the International Association for the Study of Pain (I.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - According to the International Association for the Study of Pain (IASP) Pain is an unpleasant sensory and emotional experience associated with either actual or potential tissue damage, or described in terms of such damage. The aim of this study was to assess the comparative efficacy of different NSAIDs in patients diagnosed with low back pain. Our objective of the study was to improve quality of life for the patient, to compare analgesic effect and complication of non-steroidal anti-inflammatory drugs(NSAIDs) in painful conditions, To reduce the incidence and severity of pain and, in some cases, help minimize further health problems, to reduce morbidity, to provide professional staff with standard of practice that will assist them in the effective assessment, monitoring and management of the resident s pain.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Diabetes mellitus has become a major cause of illness and disability across the world. The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalence of diabetes and the number of people affected by diabetes now and in the future is important to allow rational planning and allocation of resources. Epidemiological data for India indicates that people affected by diabetes in India presently are about 31,196,000 and projections for 2030 in India are about 79,441,000 as reported in the World Health Organization [WHO] Global Burden of Disease Study. The present work discusses the importance of the antidiabetic therapies in altering the Quality of Life and cognitive parameters in diabetic conditions. The outcome of the study will measure the efficacy of antidiabetic drug on quality of life and cognitive function of the diabetic patients. The comparative efficacy of the antidiabetic drugs used in the treatment of diabetic patients in relation to Sociodemographic and lifestyle characteristics on their Quality of Life and cognitive paradigms will also be revealed.